We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+16.55%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.43B
AUM Growth
+$203M
Cap. Flow
+$23.3M
Cap. Flow %
1.63%
Top 10 Hldgs %
47.17%
Holding
186
New
16
Increased
59
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.7M
2
ORCL icon
Oracle
ORCL
+$5.36M
3
PLD icon
Prologis
PLD
+$4.68M
4
OKTA icon
Okta
OKTA
+$3.46M
5
AEP icon
American Electric Power
AEP
+$2.54M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.32M
2
TROW icon
T. Rowe Price
TROW
+$3.96M
3
AAPL icon
Apple
AAPL
+$3.38M
4
HAS icon
Hasbro
HAS
+$2.96M
5
RTX icon
RTX Corp
RTX
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.24%
2 Technology 16.25%
3 Healthcare 13.1%
4 Financials 10.83%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FE icon
151
FirstEnergy
FE
$28B
$368K 0.03%
9,500
+2,775
+41% +$115K
BA icon
152
Boeing
BA
$171B
$367K 0.03%
2,000
+200
+11% +$30.7K
WMB icon
153
Williams Companies
WMB
$87.5B
$361K 0.03%
+19,000
New +$354K
IEP icon
154
Icahn Enterprises
IEP
$5.24B
$349K 0.02%
+7,200
New +$354K
FULT icon
155
Fulton Financial
FULT
$4.66B
$343K 0.02%
32,600
– –
DEO icon
156
Diageo
DEO
$49B
$336K 0.02%
2,500
– –
V icon
157
Visa
V
$684B
$328K 0.02%
+1,700
New +$311K
NOC icon
158
Northrop Grumman
NOC
$77.1B
$307K 0.02%
1,000
– –
SEE
159
DELISTED
Sealed Air
SEE
$302K 0.02%
9,200
– –
GSK icon
160
GSK
GSK
$104B
$298K 0.02%
5,840
-640
-10% -$32.8K
MCHP icon
161
Microchip Technology
MCHP
$40.3B
$287K 0.02%
+5,450
New +$245K
BOH icon
162
Bank of Hawaii
BOH
$3.15B
$276K 0.02%
4,500
– –
NVO
163
Novo Nordisk
NVO
$208B
$275K 0.02%
8,400
– –
SAIC icon
164
Saic
SAIC
$4.95B
$272K 0.02%
3,500
– –
IRM icon
165
Iron Mountain
IRM
$36.4B
$266K 0.02%
10,201
– –
KMI icon
166
Kinder Morgan
KMI
$71.7B
$265K 0.02%
17,447
– –
CI icon
167
Cigna
CI
$73.7B
$263K 0.02%
1,400
– –
SFM icon
168
Sprouts Farmers Market
SFM
$8.13B
$256K 0.02%
10,000
– –
GRA
169
DELISTED
W.R. Grace & Co.
GRA
$254K 0.02%
+5,000
New +$237K
KMB icon
170
Kimberly-Clark
KMB
$36.3B
$240K 0.02%
1,700
– –
MU icon
171
Micron Technology
MU
$930B
$231K 0.02%
+4,490
New +$212K
JCI icon
172
Johnson Controls International
JCI
$88.8B
$229K 0.02%
6,701
-1,275
-16% -$39.2K
RDS.A
173
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$212K 0.01%
+6,479
New +$222K
BIP icon
174
Brookfield Infrastructure Partners
BIP
$19.2B
$210K 0.01%
+7,650
New +$204K
FBIN icon
175
Fortune Brands Innovations
FBIN
$5.88B
$205K 0.01%
+3,744
New +$174K
4 5 6
7
8

Similar funds

HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return

Cullinan Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Cullinan Associates held 186 positions worth $1.43B, up 17% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cullinan Associates's Q2 2020 filing shows 16 new, 59 increased, 61 reduced and 5 closed positions. Its largest new stake was Okta: 20,400 shares worth $4.08M. The largest sale was Sanofi, an estimated $4.32M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2020 buy was Okta: 20,400 shares worth $4.08M.
  • Cullinan Associates added most to Amgen in Q2 2020, an estimated $28.7M increase.
  • Cullinan Associates's biggest Q2 2020 reduction was T. Rowe Price, cutting an estimated $3.96M.
  • Cullinan Associates fully exited Sanofi in Q2 2020, selling an estimated $4.32M.
  • Cullinan Associates's ten largest holdings make up 47% of its $1.43B portfolio in Q2 2020.
  • Cullinan Associates opened 16 new positions and closed 5 in Q2 2020.
  • Cullinan Associates's portfolio value rose 17% quarter-over-quarter to $1.43B.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.